艾德生物：公司已获批的30余项医疗器械注册证暂未进行相关资产评估

Core Viewpoint - The company has not conducted asset evaluations for its more than 30 approved medical device registration certificates [1] Group 1 - The company received approval for over 30 medical device registration certificates [1] - Investors inquired about the asset evaluation of these registration certificates on an investor interaction platform [1] - The company confirmed that no asset evaluations have been performed for the registered certificates [1]